A Randomized Controlled Trial of a Wearable Core Body Temperature Sensor Versus Standard Temperature Monitoring for Early Detection of Cytokine Release Syndrome in Patients Undergoing CAR T-Cell Therapy in an Outpatient Setting (opens ClinicalTrials.gov)
- Sponsor
- Wake Forest University Health Sciences
- Enrolment
- 105
- Started
- 2026-12
- Last update
- 2026-11-02
Conditions: Myeloma
Interventions: TempShield Continuous Temperature Monitoring, Standard of Care